Dr Ricky Lee Snyder, DO | |
Unit 33100 Box Landstuhl, Apo, AE 09180-3100 | |
(314) 590-7289 | |
Not Available |
Full Name | Dr Ricky Lee Snyder |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | Unit 33100 Box Landstuhl, Apo, Armed Forces Europe |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427121656 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 1184 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ricky Lee Snyder, DO Unit 33100 Box Landstuhl, Apo, AE 09180-3100 Ph: (314) 590-7289 | Dr Ricky Lee Snyder, DO Unit 33100 Box Landstuhl, Apo, AE 09180-3100 Ph: (314) 590-7289 |
News Archive
A genetic condition that attacks multiple organs and usually results in fatal heart problems can be detected using a new MRI technique that was developed at the University of Alberta. The discovery of this new diagnostic tool has resulted in updated clinical guidelines for the diagnosis and treatment of Fabry disease in Canada.
Metabolic syndrome affects nearly 30 percent of the U.S. population, and increases the risk for type 2 diabetes, heart disease and stroke. But lifestyle interventions such as adopting a healthy diet and increasing physical exercise are difficult to maintain and, even when combined with medication, are often insufficient to fully manage the disease.
Howard Rodgers remembers the day his son was born. His mind was teeming with positive thoughts about how this small child would change the world. Then, reality came back - for a very long visit. His son was diagnosed with one of the worst cases of autism doctors and specialists had ever seen.
Drug treatments for breast cancer patients might soon be designed based on the unique genetic autograph of their tumor.
Mylan Inc. has announced that its subsidiary, Genpharm ULC, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules, 5 mg and 10 mg.
› Verified 3 days ago
Dr. Talitha Moon, DO, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: Sudlager 301, Apo, AE 92249 Phone: 314-590-2402 | |
Dr. Timothy D. Robinette, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86th Mdg Unit 3215, Apo, AE 09094 Phone: 314-480-4675 | |
John William Kieffer, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 3215, Apo, AE 09094 Phone: 637-146-2273 | |
Dr. Donald Walter Robinson, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Hhc, Asg-ku, Attn: Medical, Apo, AE 09366 Phone: 706-239-9678 | |
Dr. Jeffrey Michael Diffenderfer, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-542-3080 | |
Dr. Sonia Leigh Molchan, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: Unit 3215, Apo, AE 09094 Phone: 637-146-2609 | |
Dr. Admirado Adolfo Luzuriaga, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg Unit 3215, Apo, AE 09094 Phone: 004-963-71462609 |